跳到正文

Defilade Capital Management, L.P. 13F 持仓 · 2026年Q2

Defilade Capital Management 在 2026年Q2(报告期截至 2026-06-30)的 SEC 13F 申报中报告了 39 只证券,申报市值合计 7.47 亿美元。前几大持仓:LLY(6.28%)、PFE(5.71%)、VEEV(5.62%)。本季前 25 大持仓中:新建仓 12 只、增持 6 只、减持 7 只。

排名代码公司市值占组合股数变动
1LLYELI LILLY & CO$46.9M6.28%39,086增持
2PFEPFIZER INC$42.7M5.71%1.8M增持
3VEEVVEEVA SYS INC$42.0M5.62%236,709新建仓
4BMRNBIOMARIN PHARMACEUTICAL INC$39.0M5.22%682,005新建仓
5PTCTPTC THERAPEUTICS INC$35.4M4.74%433,699增持
6BAXBAXTER INTL INC$31.1M4.17%1.5M新建仓
7INSMINSMED INC$30.0M4.02%281,838增持
8ZBHZIMMER BIOMET HOLDINGS INC$27.3M3.66%317,426减持
9PODDINSULET CORP$26.9M3.61%176,932新建仓
10TMOTHERMO FISHER SCIENTIFIC INC$26.0M3.49%51,934新建仓
11ABTABBOTT LABORATORIES$25.9M3.47%285,778新建仓
12ASNDASCENDIS PHARMA A/S$25.3M3.39%94,843新建仓
13SOLVSOLVENTUM CORP$24.4M3.27%316,454新建仓
14MDTMEDTRONIC PLC$23.7M3.18%303,301新建仓
15ELANELANCO ANIMAL HEALTH INC$21.3M2.85%864,080减持
16AGIOAGIOS PHARMACEUTICALS INC$20.3M2.72%546,848新建仓
17NVSTENVISTA HOLDINGS CORPORATION$19.1M2.56%726,108新建仓
18RVMDREVOLUTION MEDICINES INC$15.5M2.08%82,827减持
19ICUIICU MED INC$15.5M2.07%105,700减持
20COGTCOGENT BIOSCIENCES INC$15.2M2.04%393,441增持
21LNTHLANTHEUS HLDGS INC$14.7M1.97%132,662减持
22OCULOCULAR THERAPEUTIX INC$14.6M1.96%1.5M增持
23ELDNELEDON PHARMACEUTICALS INC$13.9M1.86%3.5M减持
24TYRATYRA BIOSCIENCES INC$12.0M1.61%376,870新建仓
25OLMAOLEMA PHARMACEUTICALS INC$11.6M1.55%924,758减持

来源:SEC 13F 申报文件 · 截至 2026-06-30

本期 13F-HR 中的全部持仓,以及相对上季度的变化。

13F 持仓,最新季度

来源SEC EDGAR13F-HR